Genetic deficiency of Smad3 protects against murine ischemic acute kidney injury

American Journal of Physiology - Renal Physiology

Volumn 301, Issue 2, 2011, Pages

  Nath, Karl A ^a   Croatt, Anthony J ^a   Warner, Gina M ^b   Grande, Joseph P ^b  

^a Division of Nephrology and Hypertension   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Chronic kidney disease; Heme oxygenase 1; IL 6; TGF 1

Indexed keywords

ENDOTHELIN 1; HEME OXYGENASE 1; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SMAD3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY ISCHEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; QUALITATIVE ANALYSIS; RENAL PROTECTION; SHAM PROCEDURE; UPREGULATION; UREA NITROGEN BLOOD LEVEL;

EID: 79961203984     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00162.2011     Document Type: Article

References (51)

1. Aoki H, Ohnishi H, Hama K, Shinozaki S, Kita H, Yamamoto H, Osawa H, Sato K, Tamada K, Sugano K. Existence of autocrine loop between interleukin-6 and transforming growth factor-beta1 in activated rat pancreatic stellate cells. J Cell Biochem 99: 221-228, 2006.
2. Basile DP, Martin DR, Hammerman MR. Extracellular matrix-related genes in kidney after ischemic injury: potential role for TGF-fj in repair. Am J Physiol Renal Physiol 275: F894-F903, 1998.
3. Basile DP, Rovak JM, Martin DR, Hammerman MR. Increased transforming growth factor-p1 expression in regenerating rat renal tubules following ischemic injury. Am J Physiol Renal Fluid Electrolyte Physiol 270: F500-F509, 1996.
4. Bottinger EP. TGF-beta in renal injury and disease. Semin Nephrol 27: 309-320, 2007.
5. Castanares C, Redondo-Horcajo M, Magan-Marchal N, ten Dijke P, Lamas S, Rodriguez-Pascual F. Signaling by ALK5 mediates TGF-beta-induced ET-1 expression in endothelial cells: a role for migration and proliferation. J Cell Sci 120: 1256-1266, 2007.
6. Chawla LS, Seneff MG, Nelson DR, Williams M, Levy H, Kimmel PL, Macias WL. Elevated plasma concentrations of IL-6 and elevated APACHE II score predict acute kidney injury in patients with severe sepsis. Clin J Am Soc Nephrol 2: 22-30, 2007.
7. Cheng J, Grande JP. Transforming growth factor-beta signal transduction and progressive renal disease. Exp Biol Med (Maywood) 227: 943-956, 2002.
8. Deelman L, Sharma K. Mechanisms of kidney fibrosis and the role of antifibrotic therapies. Curr Opin Nephrol Hypertens 18: 85-90, 2009.
9. Dennen P, Altmann C, Kaufman J, Klein CL, Andres-Hernando A, Ahuja NH, Edelstein CL, Cadnapaphornchai MA, Keniston A, Faubel S. Urine interleukin-6 is an early biomarker of acute kidney injury in children undergoing cardiac surgery. Crit Care 14: R181, 2010.
10. Donnahoo KK, Meng X, Ayala A, Cain MP, Harken AH, Meldrum DR. Early kidney TNF-a expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am J Physiol Regul Integr Comp Physiol 277: R922-R929, 1999.
11. Furuichi K, Wada T, Iwata Y, Kitagawa K, Kobayashi K, Hashimoto H, Ishiwata Y, Asano M, Wang H, Matsushima K, Takeya M, Kuziel WA, Mukaida N, Yokoyama H. CCR2 signaling contributes to ischemia-reperfusion injury in kidney. J Am Soc Nephrol 14: 2503-2515, 2003.
12. Furuichi K, Wada T, Iwata Y, Kitagawa K, Kobayashi K, Hashimoto H, Ishiwata Y, Tomosugi N, Mukaida N, Matsushima K, Egashira K, Yokoyama H. Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia-reperfusion injury. J Am Soc Nephrol 14: 1066-1071, 2003.
13. Ge Q, Moir LM, Black JL, Oliver BG, Burgess JK. TGFbeta1 induces IL-6 and inhibits IL-8 release in human bronchial epithelial cells: the role of Smad2/3. J Cell Physiol 225: 846-854, 2010.
14. Geng H, Lan R, Wang G, Siddiqi AR, Naski MC, Brooks AI, Barnes JL, Saikumar P, Weinberg JM, Venkatachalam MA. Inhibition of autoregulated TGFbeta signaling simultaneously enhances proliferation and differentiation of kidney epithelium and promotes repair following renal ischemia. Am J Pathol 174: 1291-1308, 2009.
15. Guan Q, Nguan CY, Du C. Expression of transforming growth factor-beta1 limits renal ischemia-reperfusion injury. Transplantation 89: 1320-1327, 2010.
16. Hill-Kapturczak N, Truong L, Thamilselvan V, Visner GA, Nick HS, Agarwal A. Smad7-dependent regulation of heme oxygenase-1 by trans-forming growth factor-beta in human renal epithelial cells. J Biol Chem 275: 40904-40909, 2000.
17. Hunley TE, Kon V. Endothelin in ischemic acute renal failure. Curr Opin Nephrol Hypertens 6: 394-400, 1997.
18. Ikushima H, Miyazono K. TGFbeta signalling: a complex web in cancer progression. Nat Rev Cancer 10: 415-424, 2010.
19. Jarmi T, Agarwal A. Heme oxygenase and renal disease. Curr Hypertens Rep 11: 56-62, 2009.
20. Juncos JP, Grande JP, Croatt AJ, Hebbel RP, Vercellotti GM, Katu-sic ZS, Nath KA. Early and prominent alterations in hemodynamics, signaling, and gene expression following renal ischemia in sickle cell disease. Am J Physiol Renal Physiol 298: F892-F899, 2010.
21. Juncos JP, Grande JP, Murali N, Croatt AJ, Juncos LA, Hebbel RP, Katusic ZS, Nath KA. Anomalous renal effects of tin protoporphyrin in a murine model of sickle cell disease. Am J Pathol 169: 21-31, 2006.
22. Kielar ML, John R, Bennett M, Richardson JA, Shelton JM, Chen L, Jeyarajah DR, Zhou XJ, Zhou H, Chiquett B, Nagami GT, Lu CY. Maladaptive role of IL-6 in ischemic acute renal failure. J Am Soc Nephrol 16: 3315-3325, 2005.
23. Klein CL, Hoke TS, Fang WF, Altmann CJ, Douglas IS, Faubel S. Interleukin-6 mediates lung injury following ischemic acute kidney injury or bilateral nephrectomy. Kidney Int 74: 901-909, 2008.
24. Kohan DE. Endothelins in the normal and diseased kidney. Am J Kidney Dis 29: 2-26, 1997.
25. Kwon O, Molitoris BA, Pescovitz M, Kelly KJ. Urinary actin, interleukin-6, and interleukin-8 may predict sustained ARF after ischemic injury in renal allografts. Am J Kidney Dis 41: 1074-1087, 2003.
26. Lee HT, Chen SW, Doetschman TC, Deng C, D'Agati VD, Kim M. Sevoflurane protects against renal ischemia and reperfusion injury in mice via the transforming growth factor-p1 pathway. Am J Physiol Renal Physiol 295: F128-F136, 2008.
27. Lee HT, Kim M, Kim J, Kim N, Emala CW. TGF-beta1 release by volatile anesthetics mediates protection against renal proximal tubule cell necrosis. Am J Nephrol 27: 416-424, 2007.
28. Lee HT, Kim M, Song JH, Chen SW, Gubitosa G, Emala CW. Sevoflurane-mediated TGF-fj1 signaling in renal proximal tubule cells. Am J Physiol Renal Physiol 294: F371-F378, 2008.
29. Liu KD, Altmann C, Smits G, Krawczeski CD, Edelstein CL, Devara-jan P, Faubel S. Serum interleukin-6 and interleukin-8 are early biomark-ers of acute kidney injury and predict prolonged mechanical ventilation in children undergoing cardiac surgery: a case-control study. Crit Care 13: R104, 2009.
30. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 69: 213-217, 2006.
31. Meldrum KK, Meldrum DR, Meng X, Ao L, Harken AH. TNF-α-dependent bilateral renal injury is induced by unilateral renal ischemia-reperfusion. Am J Physiol Heart Circ Physiol 282: H540-H546, 2002.
32. Meng XM, Huang XR, Chung AC, Qin W, Shao X, Igarashi P, Ju W, Bottinger EP, Lan HY. Smad2 protects against TGF-beta/Smad3-medi-ated renal fibrosis. J Am Soc Nephrol 21: 1477-1487, 2010.
33. Meulmeester E, Ten Dijke P. The dynamic roles of TGF-beta in cancer. J Pathol 223: 205-218, 2011.
34. Munshi R, Johnson A, Siew ED, Ikizler TA, Ware LB, Wurfel MM, Himmelfarb J, Zager RA. MCP-1 gene activation marks acute kidney injury. J Am Soc Nephrol 22: 165-175, 2011.
35. Nath KA. Heme oxygenase-1: a provenance for cytoprotective pathways in the kidney and other tissues. Kidney Int 70: 432-443, 2006.
36. Nath KA, Croatt AJ, Haggard JJ, Grande JP. Renal response to repetitive exposure to heme proteins: chronic injury induced by an acute insult. Kidney Int 57: 2423-2433, 2000.
37. Nath KA, Grande JP, Croatt AJ, Frank E, Caplice NM, Hebbel RP, Katusic ZS. Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury. Am J Pathol 166: 963-972, 2005.
38. Patel NS, Chatterjee PK, di Paola R, Mazzon E, Britti D, de Sarro A, Cuzzocrea S, Thiemermann C. Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfu-sion. J Pharmacol Exp Ther 312: 1170-1178, 2005.
39. Pittock ST, Norby SM, Grande JP, Croatt AJ, Bren GD, Badley AD, Caplice NM, Griffin MD, Nath KA. MCP-1 is up-regulated in unstressed and stressed HO-1 knockout mice: pathophysiologic correlates. Kidney Int 68: 611-622, 2005.
40. Roberts AB, Tian F, Byfield SD, Stuelten C, Ooshima A, Saika S, Flanders KC. Smad3 is key to TGF-beta-mediated epithelial-to-mesen-chymal transition, fibrosis, tumor suppression and metastasis. Cytokine Growth Factor Rev 17: 19-27, 2006.
41. Rodriguez-Pascual F, Redondo-Horcajo M, Lamas S. Functional cooperation between Smad proteins and activator protein-1 regulates transforming growth factor-beta-mediated induction of endothelin-1 expression. Circ Res 92: 1288-1295, 2003.
42. Schnaper HW, Jandeska S, Runyan CE, Hubchak SC, Basu RK, Curley JF, Smith RD, Hayashida T. TGF-beta signal transduction in chronic kidney disease. Front Biosci 14: 2448-2465, 2009.
43. Shiraishi F, Curtis LM, Truong L, Poss K, Visner GA, Madsen K, Nick HS, Agarwal A. Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis. Am J Physiol Renal Physiol 278: F726-F736, 2000.
44. Simmons EM, Himmelfarb J, Sezer MT, Chertow GM, Mehta RL, Paganini EP, Soroko S, Freedman S, Becker K, Spratt D, Shyr Y, Ikizler TA. Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int 65: 1357-1365, 2004.
45. Spurgeon KR, Donohoe DL, Basile DP. Transforming growth factor-3 in acute renal failure: receptor expression, effects on proliferation, cellu-larity, and vascularization after recovery from injury. Am J Physiol Renal Physiol 288: F568-F577, 2005.
46. Tanaka T, Nangaku M. The role of hypoxia, increased oxygen consumption, and hypoxia-inducible factor-1 alpha in progression of chronic kidney disease. Curr Opin Nephrol Hypertens 19: 43-50, 2010.
47. Tracz MJ, Juncos JP, Croatt AJ, Ackerman AW, Grande JP, Knut-son KL, Kane GC, Terzic A, Griffin MD, Nath KA. Deficiency of heme oxygenase-1 impairs renal hemodynamics and exaggerates systemic inflammatory responses to renal ischemia. Kidney Int 72: 1073-1080, 2007.
48. Tracz MJ, Juncos JP, Grande JP, Croatt AJ, Ackerman AW, Rajago-palan G, Knutson KL, Badley AD, Griffin MD, Alam J, Nath KA.Renal hemodynamic, inflammatory, and apoptotic responses to lipopoly-saccharide in HO-1-/- mice. Am J Pathol 170: 1820-1830, 2007.
49. Venkatachalam MA, Griffin KA, Lan R, Geng H, Saikumar P, Bidani AK. Acute kidney injury: a springboard for progression in chronic kidney disease. Am J Physiol Renal Physiol 298: F1078-F1094, 2010.
50. Zager RA, Johnson AC, Hanson SY, Lund S. Ischemic proximal tubular injury primes mice to endotoxin-induced TNF-a generation and systemic release. Am J Physiol Renal Physiol 289: F289-F297, 2005.
51. Zhang D, Sun L, Xian W, Liu F, Ling G, Xiao L, Liu Y, Peng Y, Haruna Y, Kanwar YS. Low-dose paclitaxel ameliorates renal fibrosis in rat UUO model by inhibition of TGF-beta/Smad activity. Lab Invest 90: 436-447, 2010.